Company intelligence / Profile preview

Mezzopointe

Ownership: Private
Development stage: Other

Overview

Mezzopointe is a privately-held R&D strategy consulting firm specializing in optimizing the value of commercialization and/or exit for biotechnology companies. The company provides customized analyses and strategic guidance to biopharma clients, with expertise spanning M&A valuation, clinical trial landscape analysis (notably in pediatrics), and regulatory strategy[1][8].

Industry: Consulting

Partnerships

FDA ADEPT9 Planning Committee (collaborative involvement via leadership)[1][8]

Beyond the preview

Go deeper on Mezzopointe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mezzopointe.

Explore the full profile